Dynamics of BCR-ABL Kinase Domain Mutations in Patients with Chronic Myeloid Leukemia (CML) after Treatment with One, Two or Three Tyrosine Kinase Inhibitors (TKI).
Authors:
Open Access
- 16 November 2006
- journal article
- Published by American Society of Hematology in Blood
- Vol. 108 (11) , 750